Jane Street Group, LLC Relay Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 185,329 shares of RLAY stock, worth $770,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,329

Previous 198,402 6.59%

Holding current value

$770,968

Previous $1.29 Million 1.47%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.23 - $9.51 $81,444 - $124,324	-13,073 Reduced 6.59%	185,329 $1.31 Million
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $336,081 - $456,843	56,963 Added 40.27%	198,402 $1.29 Million
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $661,507 - $1.06 Million	88,201 Added 165.67%	141,439 $1.17 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $1.13 Million - $2.15 Million	-187,432 Reduced 77.88%	53,238 $586,000
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $1.48 Million - $2.32 Million	179,158 Added 291.26%	240,670 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $159,040 - $290,858	15,920 Added 34.92%	61,512 $772,000
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $503,820 - $764,462	33,588 Added 279.81%	45,592 $750,000
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $169,976 - $288,336	12,004 New	12,004 $179,000
Q2 2022 Aug 16, 2022	SELL	$13.31 - $34.88 $80,485 - $210,919	-6,047 Reduced 23.47%	19,716 $330,000
Q1 2022 May 17, 2022	BUY	$20.26 - $32.36 $521,958 - $833,690	25,763 New	25,763 $771,000
Q4 2021 Feb 15, 2022	SELL	$26.0 - $37.03 $503,464 - $717,048	-19,364 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$29.75 - $37.99 $576,079 - $735,638	19,364 New	19,364 $611,000
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $488,895 - $678,941	-17,778 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$32.52 - $61.53 $578,140 - $1.09 Million	17,778 New	17,778 $615,000

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Relay Therapeutics, Inc. Transaction History